YUHEFHomo sapiens (Human)Cancer cell line

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_G326
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Additional Information
  • Established from the lung metastatic melanoma cells of Robert V. Heffernan (the 'HEF' in the cell name) who wrote about his successful fight against cancer in an autobiographical book (CelloPub=CLPUB00386)

Disease Information

DiseaseCutaneous melanoma

DepMap Information

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNF1p.Lys2552Thrfs*2Unspecified-PubMed=26214590
MutationSimpleNF1p.Gln853Ter (c.2557C>T)Unspecified-PubMed=26214590

Publications

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas.

Schlessinger J., Lifton R.P., Halaban R.

Nat. Genet. 47:996-1002(2015).

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Lifton R.P., Schlessinger J., Boggon T.J., Halaban R.

Nat. Genet. 44:1006-1014(2012).

MicroRNA signatures differentiate melanoma subtypes.";

Krauthammer M., Tuck D., Slack F.J., Weidhaas J.B.

Cell Cycle 10:1845-1852(2011).

Phosphoproteomic screen identifies potential therapeutic targets in melanoma.

Muthusamy V., Bosenberg M.W., Krauthammer M., Halaban R., Stern D.F.

Mol. Cancer Res. 9:801-812(2011).

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Krauthammer M., McCusker J.P., Kluger Y., Sznol M.

Pigment Cell Melanoma Res. 23:190-200(2010).